Compound 281
Identifiers
- Canonical SMILES:
CC(C)CN(Cc1cc(Cl)cc(CN(CC(C)C)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1)C(=O)c1cccc(c1)S(=O)(=O)C(F)(F)F
- IUPAC name:
N-[[3-chloro-5-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-(2-methylpropyl)amino]methyl]phenyl]methyl]-N-(2-methylpropyl)-3-(trifluoromethylsulfonyl)benzamide
- InChi:
InChI=1S/C30H32Cl3F3N2O6S2/c1-18(2)14-37(29(40)22-6-5-7-25(11-22)45(41,42)30(34,35)36)16-20-8-21(10-23(31)9-20)17-38(15-19(3)4)46(43,44)27-13-24(32)12-26(33)28(27)39/h5-13,18-19,39H,14-17H2,1-4H3
- InChiKey:
CZGXXZXSMNQLKU-UHFFFAOYSA-N
External links
58531644 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 73 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.50 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 742.07 g/mol | |||
HBA | 8 | |||
HBD | 1 | |||
HBA + HBD | 9 | |||
AlogP | 8.72 | |||
TPSA | 112.06 | |||
RB | 12 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 73 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.50 | |
WO2009152082 | 73 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.42 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5233 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4857 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4817 | Clorexolone | DB13617 | |
0.4611 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | DB07691 | |
0.4520 | N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide | DB08429 | |
0.4486 | Glyburide | DB01016 | |
0.4483 | Saccharin | DB12418 | |
0.4475 | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | DB08000 | |
0.4428 | Repinotan | DB06506 | |
0.4414 | Sulfabenzamide | DB09355 | |
0.4386 | Sulpiride | DB00391 | |
0.4353 | Xipamide | DB13803 | |
0.4352 | CGS-27023 | DB07556 | |
0.4318 | Sultopride | DB13273 | |
0.4312 | Tiapride | DB13025 |